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Abstract
Background
Drugs currently used for the treatment of Chagas’ disease, nifurtimox and benznidazole,
have a limited effectiveness and toxic side effects. With the aim of finding new therapeutic
approaches, in vitro and in vivo anti-Trypanosoma cruzi activity of vitamin C alone and com-
bined with benznidazole were investigated.
Methodology/Principal findings
The trypanocidal activity on epimastigote and trypomastigote forms was evaluated by count-
ing parasites in a Neubauer chamber after treatment with the compounds. For the amasti-
gote stage, transgenic parasites expressing β-galactosidase were used and quantified by
measuring the β-galactosidase activity. The cytotoxicity of compounds was tested on Vero
cells. The redox state of the parasite was evaluated by determining the reduced thiol levels
(spectrophotometric assay) and the intracellular oxidative state (by flow cytometry). The in
vivo trypanocidal activity was evaluated on a murine model of Chagas’ disease. The trypa-
nocidal activity of vitamin C and benznidazole was similar for the three parasite forms.
When combining both drugs, vitamin C did not induce any change in the antiparasitic activity
of benznidazole on trypomastigotes; however, on mammal cells, vitamin C diminished the
cytotoxicity degree of benznidazole. Two mechanisms of action may be postulated for vita-
min C: a lethal pro-oxidant effect on the parasite when used alone, and an antioxidant effect,
when combined with benznidazole. A similar behavior was observed on infected mice; i.e.,
parasite counts in infected mice treated with vitamin C were lower than that of the control
group. Animals treated with benznidazole presented lower parasitemia levels, as compared
with those treated with vitamin C alone. Again, vitamin C did not cause any effect on the anti-
parasitic profile of benznidazole. Even though a combined treatment was employed, the
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antioxidant effect of vitamin C on the host was evidenced; a 100% survival was observed
and the weight loss occurring during the acute phase of the infection was reduced.
Conclusions/Significance
Based on these results, the combination of vitamin C with benznidazole could be considered
as an alternative treatment for Chagas’ disease. These preliminary results encourage fur-
ther research to improve the treatment of Chagas’ disease.
Author summary
The huge worldwide expansion of Chagas’ disease (American trypanosomiasis) that has
occurred as a result of the population mobility from Latin America, has caused this para-
sitic disease to become an important topic for the World Health Organization. Cases of
Chagas’ disease have been reported in the United States and Canada, as well as in Europe
and the Western Pacific. The efficacy of current drugs (nifurtimox and benznidazole) to
treat this disease is limited. Besides, these drugs cause adverse effects. For these reasons, a
continuous research to find therapeutic alternatives is required. In our laboratory, we
evaluate the anti-Trypanosoma cruzi effect of both synthetic and natural products. Promis-
ing results have been obtained in our laboratory when the effect of vitamin B12 was tested
on infected mice. As a continuation of that work, herein we evaluated the effects of the
combined treatment of vitamin C and benznidazole as a therapeutic alternative. Vitamin
C was found to diminish the cytotoxicity of the antichagasic drug.
Introduction
Trypanosoma cruzi is the causative agent of Chagas’ disease, which was declared of worldwide
interest by the World Health Organization (WHO) [1]. To fight this illness that originated in
Latin America (American trypanosomiasis), nifurtimox and benznidazole (Bnz) are used.
These drugs are known to cause considerable secondary effects and have limited effectiveness.
For this reason, over the past years, studies have been undertaken to find novel therapeutic
alternatives to treat this disease.
Many drugs have been reported to exert their anti-T. cruzi effect through the generation of
reactive oxygen species (ROS) [2–4]. The infection with T. cruzi is known to cause and inflam-
matory response together with the generation of oxidative stress, which plays a central role in
the pathophysiology of the disease [5–8]. Both events suggest that the production of ROS
could be an efficient strategy against the parasite. It is known that ascorbic acid or vitamin C
(Vit C) exerts a dual effect, acting as antioxidant at physiological concentrations (40–80 μM),
and as a pro-oxidant at pharmacological high concentrations (1 to 5 mM, achieved only by
intravenous administration) [9,10]. Ascorbate acts as an antioxidant neutralizing potentially
harmful free radicals, while as pro-oxidant, in the presence of catalytic metallic ions, ascorbate
induces the formation of H2O2 and ROS.
The pro-oxidant effect is the main mechanism by which high doses of Vit C cause cell
death. Thus, Vit C can manifest its known selective cytotoxic effect on tumor cells, which are
particularly vulnerable to the oxidative stress induced by H2O2 [10–12]. Such pro-oxidant
effect could also account for the antiparasitic activity previously demonstrated in our labora-
tory when T. cruzi parasites were treated with a combination of Vitamin B12 and Vit C [3]. In
Anti-T. cruzi activity of vitamin C
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this case, the induction of the toxic effect would be mediated by cobalt ions contained in the
corrinic ring of the vitamin B12.
T. cruzi can either synthesize ascorbic acid or obtain it from the culture medium [13]. Our
hypothesis is that Vit C has the capacity to kill the parasite acting as a pro-oxidant compound
by reacting with traces of heavy metal ions present inside the parasite´s cytoplasm and/or pro-
tect the host from the oxidative stress generated by the T. cruzi infection. Thus, the antipara-
sitic activity of Vit C was studied in vitro on the three stages of T. cruzi, as well as in vivo using
an acute Chagas’ disease murine model. The effect caused by the combined administration of
Vit C and benznidazole (Bnz) was also assessed.
Materials and methods
Chemicals
Hemin, EDTA, NADH, RPMI-1640 culture medium, dithionitrobenzoate (DTNB) and L(+)
ascorbic acid GR (Vit C) were obtained from Sigma Chem. Co. (Saint Louis, MO, USA). Yeast
extract, tryptose and brain heart infusion (BHI) were from Difco Laboratories (Sparks, MD,
USA). Bnz was kindly provided by Roche (Argentina). All other chemicals were of the highest
purity commercially available.
Parasites
Trypanosoma cruzi epimastigotes (Tulahue´n strain) were grown at 28 ºC in a liquid medium
containing 3.3% BHI (Difco), 0.3% tryptose (Difco), 0.3% disodium phosphate, 0.04% potas-
sium chloride, 0.03% dextrose, and hemin (20 μg mL-1). After sterilization, penicillin (100 IU
mL-1), streptomycin (100 μg mL-1) and 20% v/v heat-inactivated fetal calf serum (Natocor)
were added. T. cruzi bloodstream trypomastigotes were obtained from infected CF1 mice by
cardiac puncture at the peak of parasitemia on day 15 post-infection. Trypomastigotes were
routinely maintained by infecting 21 day-old CF1 mice. T. cruzi parasites from the Tulahue´n
strain expressing the β-gal gene (Tul-β-Gal) were kindly provided by Dr. Buckner [14].
Animals
Outbred CF1 male and inbred C3H/HeN female mice were nursed at the Departamento de
Microbiologı´a, Facultad de Medicina, Universidad de Buenos Aires.
In vitro assays for anti-T. cruzi activity
To evaluate growth inhibition on epimastigotes, Vit C was tested at concentrations ranging
from 1 to 10 μM. Bnz was used as reference drug at concentrations ranging from 2.5 to 10 μM.
The percentage of inhibition (I%) and 50% inhibitory concentration (IC50) values were esti-
mated by counting the parasites in a Neubauer chamber, as previously described [3].
The trypanocidal activity was also evaluated on bloodstream trypomastigotes. Parasites
were cultured in the presence of 5 to 100 μM of Vit C or 0.38 to 380 μM of Bnz, under the con-
ditions stated elsewhere [3]. Living parasites were then counted in a Neubauer chamber and
the percentage of lysis (% L) and the concentration that causes 50% lysis (IC50) were calculated
as previously reported [3].
The growth inhibition of amastigotes was determined in J774 murine macrophages cultures
infected with transgenic trypomastigotes expressing β-galactosidase (Tul- β-Gal). Vit C and
Bnz were assayed from 0.5 to 40 μM. Parasite counts were then determined spectrophotomet-
rically by measuring the product of the enzymatic reaction. I% and IC50 values were then cal-
culated as previously described [3].
Anti-T. cruzi activity of vitamin C
PLOS Neglected Tropical Diseases | https://doi.org/10.1371/journal.pntd.0006764 September 21, 2018 3 / 13
Cytotoxic activity
The cytotoxicity assay was carried out in vitro, on Vero cells (from the Departamento de Quı´mica
Biolo´gica, Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires). Briefly, cells
were seeded on a 24-well plate. Each well contained 500 μL of a cell suspension at 9x105 cells mL-1.
The plate was then incubated for 24 h at 37˚C. After this period, Vit C (from 5 to 5000 μM) and
Bnz (3 to 3000 μM) was added. The plate was incubated for 48 h at 37˚C. After incubation, the cul-
ture medium was replaced with phosphate buffered saline PBS and MTT was added at a final con-
centration of 0.5 mg/ml. Cells were incubated for 1 h at 37˚C and then resuspended in 500 μL of
dimethyl sulfoxide (DMSO). The absorbance was read at 570 nm using an ELISA plate reader.
Absorbance values of wells containing only medium and reagents were used as blank reaction.
MTT assays were done in triplicate. The 50% cytotoxic concentration (CC50) was defined as that
causing a 50% of death. The selectivity index (SI) was calculated as CC50/IC50.
Intracellular redox state assays
The intracellular redox state was measured on 4-day-growth epimastigotes treated with differ-
ent concentrations of Vit C (5, 15 and 30 μM) during 2, 5, 8 and 10 h. The following assays
were then carried out.
The content of thiol groups was determined by measuring the change in light absorbance
(410 nm) occurring when SH-groups reduce DTNB. The quantification was carried out in
cell-free extract, following the methodology described previously [15].
The intracellular oxidative stress was evaluated by flow cytometry using 2’,7’-dichlorodihy-
drofluorescein diacetate (H2DCFDA) as fluorescent probe, following the methodology previ-
ously described [4]. The fluorescence intensity of the oxidized probe was measured in a Becton
Dickinson FACScalibur flow cytometer. Results were analyzed using the FlowJo V10 software
and the ratio Gmt/Gmc was determined, where Gmt and Gmc correspond to the geometric
mean of histograms obtained with treated and untreated (control) cells, respectively.
In vivo trypanocidal activity assay
Six to eight week-old C3H/HeN mice were infected with 5x103 trypomastigotes through the intra-
peritoneal route. Seven days after the infection, mice were treated with either Vit C (1.5 mg/kg/day)
or Bnz (0.75 mg/kg/day), or the combination of both. Bnz concentration used arise from S1 Fig.
These drugs were resuspended in 0.05M PBS (pH 7.2). The control group was treated only with the
vehicle. Drugs were administered from Monday to Friday during 2 weeks (days 7 to 12 and 15 to
20 post-infection) through the intraperitoneal route. Parasitemia levels were monitored every other
day by counting parasites in a Neubauer chamber, and using 5 μl of blood diluted 1:5 in lysis buffer
(0.75% NH4Cl, 0.2% Tris, pH 7.2). The number of dead mice was registered every day. The weight
of each animal was registered between days 9 and 16 post-infection. Results were expressed as
weight loss percentage considering 100% the body weight corresponding to day 9 post-infection.
Ethics statement
Animal experiments were approved by the Institutional Committee for the Care and Use of
Laboratory Animals (CICUAL) of Universidad de Buenos Aires, Facultad de Medicina, Argen-
tina (identification no. 2943/2013). Animals received human care and were treated in accor-
dance with guidelines established by the Animal Care and Use Committee of the Argentine
Association of Specialists in Laboratory Animals (AADEALC), which were in accordance with
the Guide for the Care and Use of the Laboratory Animals of the National Research Council of
the National Academies [16].
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Statistical analysis
All data are expressed as means ± SEM. To calculate the IC50, I% or L% values were plotted
against the log of drug concentration (μM) and fitted to a sigmoidal curve determined by a
non-linear regression (Sigma Plot 12 software). The significance of differences was evaluated
with either the Student´s t test or one-way analysis of variance (ANOVA) with post-hoc analy-
sis using the Tukey’s test. A p< 0.05 was considered significant. Parasitemia and weight loss
were analyzed using the non-parametric Mann-Whitney’s U test. Parasitemia was also
expressed as Area Under the Curve (AUC). Survival curves were compared with a log-rank
test. Results presented are representative of three to four independent experiments.
Results
In vitro antiparasitic activity
The in vitro antiparasitic activity of Vit C was evaluated on the three parasite stages (Fig 1). On
epimastigotes, Vit C was found to be 1.3–1.8 times more active than Bnz, whereas Bnz was 1.4
Fig 1. Antiparasitic activity of Vit C and Bnz on T. cruzi epimastigote, trypomastigote and amastigote forms. Vit
C concentrations assayed ranged from 1 to 10 μM for epimastigotes, 5 to 100 μM for trypomastigotes and 0.5 to 40 μM
for amastigotes. For Bnz, used as reference drug, the concentrations tested ranged from 2.5 to 10 μM for epimastigotes,
0.38 to 380 μM for trypomastigotes and 0.5 to 40 μM for amastigotes. IC50 values were calculated (see Materials and
Methods) and shown in the inset table.
https://doi.org/10.1371/journal.pntd.0006764.g001
Anti-T. cruzi activity of vitamin C
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to 1.8 times more active than Vit C on bloodstream trypomastigotes. In amastigotes, similar
IC50 values were obtained for Vit C and Bnz.
In order to carry out an in vivo evaluation of the combined treatment with Vit C + Bnz, the
effect of Vit C (13.6 to 81.8 μM) in combination with Bnz (33.3 μM) on trypomastigote stage
was evaluated (Table 1).The addition of different concentrations of Vit C (which in the absence
of Bnz caused a 4–60% of lysis) to a fixed concentration of Bnz did not increase the trypanoci-
dal activity exerted by Bnz alone.
Cytotoxicity assay
Vero cells were treated with different concentrations of Vit C and Bnz (Fig 2A). Vit C did not
cause any cytotoxic effect at concentrations of up to 2500 μM. Nevertheless, higher concen-
trations (5000 μM) proved to exert a cytotoxic effect of 35%. A CC50 = 90.9 ± 2.50 μM was
obtained for Bnz. The SI is a parameter representing the cytotoxic effects of a drug in ma-
mmalian cells, and its antiparasitic activity. SI values were calculated for Vit C and Bnz on all
T. cruzi forms: for epimastigotes, the SI for Bnz was 14.12, whereas for Vit C this value was >
684.93. For trypomastigotes, SI values were 2.74 and> 49.40 for Bnz and Vit C, respectively.
For amastigotes, the SI values were 20.10 for Bnz and> 537.63 for Vit C. In order to perform
an in vivo assessment of the combined treatment with Vit C + Bnz, the effect of Vit C (5 to
5000 μM) on the cytotoxicity exerted by Bnz (100 μM) was assayed (Fig 2B). A significant
decrease in the cytotoxicity caused by Bnz was observed in the presence of Vit C at concentra-
tions ranging from 5 to 500 μM. However, this tendency was not observed when 5000 μM of
Vit C were added, since cell viability values were the lowest.
Intracellular redox state assays
Due to its pro-oxidant and/or antioxidant effect, it is postulated that Vit C would induce a
redox imbalance leading to changes in both the level of free low molecular weight thiols and
the oxidative state inside the parasite. Such changes were evaluated on T. cruzi epimastigotes
treated with different concentrations of Vit C (5, 15 and 30 μM) during short times (2, 5, 8 and
10 h). As shown in Fig 3A, a significant Vit C concentration-independent decrease in the thiol
content (~50%) was observed between 2 h and 5 h post-treatment. From 5 h until 8 h, the thiol
content increased in a Vit C concentration-dependent manner, reaching maximum values of
191% and 133% (values that were above the control), for 30 μM and 15 μM Vit C, respectively.
After reaching this maximum value, the concentration of SH-groups decreased to return to
control values after 10 h post-treatment.
Table 1. Effect of Vit C plus Bnz on T. cruzi trypomastigotes.
Compounds Lysis (%)
Control (
) 0
Bnz (33.3 μM) 41,40 ± 3.80
Vit C (13.6 μM) 3.77 ± 1.10
Vit C (13.6 μM) + Bnz (33.3 μM) 35.85 ± 1.50
Vit C (40.9 μM) 26.42 ± 3.50
Vit C (40.9 μM) + Bnz (33.3 μM) 40.40 ± 2.00
Vit C (81.8 μM) 58.94 ± 3.50
Vit C (81.8 μM) + Bnz (33.3 μM) 36.96 ± 4.20
() untreated trypomastigotes
https://doi.org/10.1371/journal.pntd.0006764.t001
Anti-T. cruzi activity of vitamin C
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Fig 2. Cytotoxic effect of Vit C and Bnz on Vero cells. (a). Cells were cultured for 48 h in the presence of different
concentrations of Vit C (5 to 5,000 μM) and Bnz (3 to 3000 μM). Cell viability was determined by the MTT assay (see
Methods). Effect of Vit C on the cytotoxicity of Bnz (b). In the presence of different concentrations of Vit C (5 to
5000 μM), the cytotoxicity of a fixed concentration of Bnz (100 μM) was evaluated. Significant differences (p<0.05),
when compared to the control, as assessed by the Student’s t-test.
https://doi.org/10.1371/journal.pntd.0006764.g002
Anti-T. cruzi activity of vitamin C
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This behavior is modified when, to the different Vit C concentrations, a fixed concentration
of Bnz (15 μM) is added (Fig 3B). An increase in the content of thiols was observed when the
concentrations of Vit C were increased (2 h post-treatment). At 5 h, minimum values of 40, 60
and 85% corresponding to 30, 15 and 5 μM Vit C, respectively were observed. Thiol levels
returned to the initial values after 8 h post-treatment and almost no variations were observed
between 8 h and 10 h. It is noteworthy that the thiol content in controls (corresponding to dif-
ferent times) observed in presence of Bnz (Fig 3B) is 3 to 5 times lower than those measured in
its absence (Fig 3A), which was at all timepoints ~153.52 nmol/mg of protein.
For the treatments described above, no changes in the parasites’ intracellular oxidative
stress (evaluated with H2DCFDA fluorescent probe) were observed, as compared to controls
(S1 Table).
In vivo antiparasitic activity
The antiparasitic activity of Vit C was measured using a murine model of acute Chagas’ dis-
ease. For this experiment, 4 groups of 6 animals each were used, which received Vit C alone or
Bnz alone or Vit C plus Bnz or PBS. At the peak of parasitemia (Fig 4A), on day 15, treated
groups had lower parasite counts, as compared to the control group (p< 0.01). While a parasi-
temia value of (60.5 ± 1.5) x 106 parasites/ml was obtained for the control group, the group
treated with Vit C alone presented a 55% decrease in such values. Mice treated with Bnz alone
or combined with Vit C presented similar parasitemia levels [(18.65 ± 1.5) x 106 and (16.66 ±
1.5) x 106 parasites/ml, respectively]. In terms of area under the parasitemia curves, decreases
of 40.45%; 58.65% and 63.79% were observed in mice treated only with Vit C, only with Bnz,
or the combination of both, respectively. While in the control group a 100% of mortality was
observed between days 14 and 29 post-infection, the group treated with Bnz + Vit C showed
100% survival until the end of the treatment period (Fig 4B). Mice treated with the combina-
tion of compounds presented a reduction of weight loss (Fig 4C), which accounts for an
improved health status.
Fig 3. Reduced thiol content during the short-time treatment with different Vit C concentrations. Epimastigotes in culture
were treated with Vit C (5, 15 or 30 μM) during 2, 5, 8 and 10 h, in the absence (a) or the presence (b) of a fixed concentration of
Bnz (15μM). The thiol content was considered 100% for parasite cultures incubated without the addition of Vit C in (a) parasites
alone and in (b) parasites treated with Bnz. At different timepoints, parasites were harvested and the thiol content was measured as
described in Methods. Significant differences (p<0.05) when compared to the control, as assessed by the Student’s t-test.
https://doi.org/10.1371/journal.pntd.0006764.g003
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Discussion
Chagas’ disease or American trypanosomiasis, currently treated with nifurtimox and Bnz,
requires new and more efficient therapeutic alternatives. Employing the Tulahue´n strain, we
observed in vitro anti-T. cruzi activity for Vit C on the three parasite forms. This activity is sim-
ilar that obtained with Bnz (Table 1). In previous studies employing the Y strain of T. cruzi, the
IC50 values obtained for Vit C, in the epimastigotes, trypomastigotes and amastigotes, were
550; 9 and 138 times higher the ones obtained herein, respectively [17]. These variations might
be caused by two reasons: the different strain of T. cruzi that was used (Y strain instead of Tula-
hue´n strain) and the range of high concentrations of Vit. C that were tested (0.35 to 2.84 mM
instead of 2.5 to 10 μM for epimastigotes, 0.09 to 1.42 mM instead of 0.38 to 380 μM for trypo-
mastigotes and 0.18 to 2.84 mM instead of 0.5 to 40 μM for amastigotes).
It is known that, depending on the concentration, Vit C can act as an antioxidant (at physi-
ological concentrations) or as a pro-oxidant agent (at pharmacological concentrations) [9,10].
As an antioxidant, ascorbate can donate an electron to potentially harmful radicals such as the
hydroxyl, alkoxyl, peroxyl, thiol and tocopheroxyl radicals; while being oxidized to the ascor-
bate radical. To act as a pro-oxidant, the presence of catalytic metal ions (such as Fe, Cu) is
Fig 4. Effect of the treatment with Vit C and Bnz on a murine model of acute Chagas’ disease. C3H mice infected with
bloodstream trypomastigotes of T. cruzi (5 x 103) were treated during days 7 to 11 and 14 to18 post-infection with either Vit C or Bnz
only, or with Vit C + Bnz. The control group corresponds to untreated infected animals. Parasitemia levels (a) were measured and the
survival (b) was monitored every day until the end of the treatment. (c) The weight loss of each animal was registered between days 9
and 16 post-infection.
https://doi.org/10.1371/journal.pntd.0006764.g004
Anti-T. cruzi activity of vitamin C
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required. In the presence of iron, ascorbate is oxidized to the ascorbate radical while it reduces
ferric (Fe3+) to ferrous (Fe2+) iron; Fe2+ can rapidly react with O2, producing the superoxide
radical and Fe3+; then superoxide radicals dismutate to H2O2 and O2. Finally, H2O2 reacts
with Fe2+ to generate, through the Fenton reaction, Fe3+ and the highly oxidant hydroxyl radi-
cal. The presence of ascorbate allows the recycling of Fe3+ to Fe2+, which again catalyzes the
formation of highly reactive oxidants from H2O2 [9,10]. NADH- and NADPH-dependent
reductases are responsible for reducing the ascorbate radical back to ascorbate [9,10]. The
harmful pro-oxidant effect of Vit C is responsible for cell death and would account for the anti-
parasitic activity observed on T. cruzi. The antiparasitic effect of Vit C is also corroborating
that, in addition to being synthesized, this compound can be captured from the environment
[13] to cause parasite death.
Unlike Bnz, which is cytotoxic, (CC50: 90.9 ± 2.50 μM), Vit C showed did not exert a cyto-
toxic effect, at least at concentrations2,500 μM (Fig 2A). Consequently, the SI value for Vit
C is>50, which is considered adequate for trypanocidal drugs [18]. Upon testing Vit C at
5,000 μM, a cytotoxic effect of ~60% was manifested. On the other hand, the cytotoxicity
exerted by 100 μM Bnz decreased significantly (from 50 to 20%) in the presence of 5 μM Vit C
(Fig 2B).
According to other researchers, the treatment with Vit C alone was not efficient at reducing
the parasitemia levels in both the acute and chronic murine model of Chagas’ disease [19,20].
Considering these results and assuming that the secondary effects could be in part related to
Bnz cytotoxicity, which significantly decreased in the presence of Vit C, it would be suitable,
and taking into account previous works, to implement a combined treatment with Vit C
+ Bnz. Therefore, the effect of such combination on the viability of trypomastigotes was evalu-
ated in in vitro assays (Table 1). Neither additive, synergistic, nor antagonistic effects were
observed. The percentage of lysis obtained with the combination of both drugs (Vit C and
Bnz) was not different from that obtained with Bnz only. This behavior indicates that the pres-
ence of Bnz would abrogate the pro-oxidant effect of Vit C.
Assuming that the level of reduced thiols is as an indicator of the cell redox state; a decrease
or an increase in reduced thiol levels could be associated with the pro-oxidant and antioxidant
effect of Vit C, respectively. Upon treating epimastigotes with high concentrations of Vit C for
short periods of time, (conditions that were previously determined as the most suitable to
detect the mode of action [3,4,21], we observed a different behavior as regards thiol levels
obtained either in the absence (Fig 3A) or the presence of Bnz (Fig 3B). In the absence of Bnz,
the pro-oxidant effect is independent of the concentration of Vit C, and precedes the antioxi-
dant effect; which is Vit. C concentration-dependent and returns the thiol levels to baseline
values at the end of the treatment (10 h). When thiol levels are determined after treatment
with both Vit C and Bnz (15 μM), first the antioxidant and then the pro-oxidant effect is
observed; being both dependent on the vitamin concentration. Metabolomics analyses have
identified that the covalent binding of Bnz, or its reduction products, to low molecular weight
thiols, as well as to protein thiols, are the main mechanism of action of Bnz on T. cruzi [22].
This fall in the thiol content caused by Bnz was considered in the control values (0 μM Vit C),
therefore it does not affect the results showed in Fig 3B, Considering the depletion of thiol lev-
els produced by Bnz, an antioxidant effect of Vit C, manifested after 2 h after the addition of
Bnz, would be expected. The latter effect would contribute to the restoration of baseline thiol
levels within the parasite. Results obtained during the first hours of treatment demonstrated a
pro-oxidant effect of Vit C in the absence of Bnz, while in the presence of this drug, the antiox-
idant effect prevails. This finding would explain the lack of pro-oxidant or antitrypanocidal
effect of Vit C when added in combination with Bnz on bloodstream trypomastigotes
(Table 1).
Anti-T. cruzi activity of vitamin C
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The treatment with different Vit C concentrations (5 μM to 30 μM) for short periods of
time (2 h to 10 h) did not affect the intracellular oxidative stage (S1 Table), thus evidencing the
efficacy of the parasite’s defense system to counteract a redox imbalance.
When evaluating the in vivo effect of Vit C alone or combined with Bnz, on a murine model
of acute Chagas’ disease, a good correlation between the parasitemia levels and the results
obtained in vitro was observed. Due to the pro-oxidant capacity, mice treated with Vit C had
parasitemia levels that were significantly lower than those of control mice, but higher than
those obtained with Bnz alone. The combined treatment did not cause a significant decrease in
the parasitemia levels, as compared to the levels obtained in animals treated with Bnz alone (in
accordance with Table 1). When Vit C is combined with Bnz, its antiparasitic/pro-oxidant
effect is not manifested; however, it could be hypothesized that an antioxidant effect would be
operating in both parasite and host; protecting the mice from the oxidative stress induced by
the infection The latter phenomenon would account for both, the 100% survival and the reduc-
tion of weight loss of mice, which accounts for an improved health status. It must be born in
mind that the antioxidant effect of Vit C has a stimulatory effect acting on several cell functions
of both the innate and adaptive immune system [23]. Therefore, the role of the immune system
in animal survival cannot be ruled out (studies currently in progress).
In this paper, the dual effect of Vit C on the parasite was demonstrated. Vit C was proved to
have a pro-oxidant effect when administered alone, and an antioxidant effect when used in
combination with Bnz. On the host, only the antioxidant effect was evident.
Based on these results, the combined therapy employing Vit C together with Bnz arises as a
promising alternative therapy for the treatment of Chagas’ disease. Vit C would also contribute
to counteract the serious secondary effects caused by Bnz.
Supporting information
S1 Fig. In vivo benznidazole trypanocidal activity. C3H/HeN mice infected with T. cruzi
were treated for 10 days (days 6 to10 and 13 to 17 post-infection) with different concentrations
of Bnz. Parasitemia was determined by counting the number of trypomastogotes in a Neu-
bauer chamber. Results shown are representative of three independent experiments.
(TIF)
S1 Table.
(PDF)
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